Global HER2 Breast Cancer Test Market (2021 to 2031) - Industry Analysis, Size, Share, Growth, Trends, and Forecasts - ResearchAndMarkets.com

·5 min read

DUBLIN, January 21, 2022--(BUSINESS WIRE)--The "HER2 Breast Cancer Test Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031" report has been added to ResearchAndMarkets.com's offering.

This report on the global HER2 breast cancer test market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031.

The report provides revenue of the global HER2 breast cancer test market for the period 2017-2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global HER2 breast cancer test market from 2021 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the HER2 breast cancer test market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global HER2 breast cancer test market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global HER2 breast cancer test market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global HER2 breast cancer test market.

The report delves into the competition landscape of the global HER2 breast cancer test market. Key players operating in the global HER2 breast cancer test market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global HER2 breast cancer test market profiled in this report.

Companies Mentioned

  • Abbott Laboratories

  • BioGenex

  • Agilent Technologies, Inc.

  • Leica Biosystems

  • Roche

  • Mylab Discovery Solutions Pvt. Ltd.

Key Questions Answered in HER2 Breast Cancer Test Market Report

  • What is the sales/revenue generated by HER2 breast cancer test procedure across all regions during the forecast period?

  • What are the opportunities in the global HER2 breast cancer test market?

  • What are the major drivers, restraints, opportunities, and threats in the market?

  • Which regional market is set to expand at the fastest CAGR during the forecast period?

  • Which segment is expected to generate the highest revenue globally in 2031?

  • Which segment is projected to expand at the highest CAGR during the forecast period?

  • What are the market positions of different companies operating in the global market?

Key Topics Covered:

1. Preface

2. Assumptions and Research Methodology

3. Executive Summary

4. Market Overview

4.1. Introduction

4.2. Global HER2 Breast Cancer Test Market Forecast

4.3. Global HER2 Breast Cancer Test Market Outlook

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunity

5. Key Insights

5.1. Revenue Model

5.2. Pricing Analysis

5.3. COVID-19 Impact Analysis

6. Global HER2 Breast Cancer Test Market Analysis, by Test Type

6.1. Introduction

6.2. Global HER2 Breast Cancer Test Market Value Share Analysis, by Test Type

6.3. Global HER2 Breast Cancer Test Market Forecast, by Test Type

6.3.1. Immunohistochemistry (IHC)

6.3.2. Fluorescence/Chromogenic In Situ Hybridization (FISH/CISH)

6.4. Global HER2 Breast Cancer Test Market Analysis, by Test Type

6.5. Global HER2 Breast Cancer Test Market Attractiveness Analysis, by Test Type

7. Global HER2 Breast Cancer Test Market Analysis, by End-user

7.1. Introduction

7.2. Global HER2 Breast Cancer Test Market Value Share Analysis, by End-user

7.3. Global HER2 Breast Cancer Test Market Forecast, by End-user

7.3.1. Hospitals

7.3.2. Diagnostic Laboratories

7.4. Global HER2 Breast Cancer Test Market Analysis, by End-user

7.5. Global HER2 Breast Cancer Test Market Attractiveness Analysis, by End-user

8. Global HER2 Breast Cancer Test Market Analysis, by Region

8.1. Introduction

8.2. Global HER2 Breast Cancer Test Market Value Share Analysis, by Region

8.3. Global HER2 Breast Cancer Test Market Forecast, by Region

8.3.1. North America

8.3.2. Europe

8.3.3. Asia Pacific

8.3.4. Latin America

8.3.5. Middle East & Africa

9. North America HER2 Breast Cancer Test Market Analysis

10. Europe HER2 Breast Cancer Test Market Analysis

11. Asia Pacific HER2 Breast Cancer Test Market Analysis

12. Latin America HER2 Breast Cancer Test Market Analysis

13. Middle East & Africa HER2 Breast Cancer Test Market Analysis

14. Competition Landscape

14.1. Market Player - Competition Matrix (by tier and size of companies)

14.2. Market Share Analysis, by Company, 2019

14.3. Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/4w987u

View source version on businesswire.com: https://www.businesswire.com/news/home/20220121005353/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting